Fusion construct and microinjection performed as described above. Positive injection was confirmed by Dot Blot (Furrer et al, 2017; Rzeszutek et al, 2022). Immunoprecipitation was performed as described before (Reuter et al, 2009; Hoehener et al, 2018). Non-crosslinking was performed because the IP of SMC4-2 under crosslinking did not work at pH below 10.4. In detail, 400-ml cells were harvest at 4 h after 100% fragmentation, pellets were resuspended in 2 ml fresh lysis buffer (50 mM Tris pH 8.8, 150 mM NaCl, 5 mM MgCl2, 1 mM DTT, 1% Triton X-100, 1× protease inhibitor complete tablet [Roche], and 10% glycerol) and sonicated until complete lysis. The cell lysates were spin down at 13,000g, 4°C for 30 min 1 ml of the supernatant was incubated with 50 μl of Anti-HA affinity resin (Roche) overnight at 4°C while rotating. Another 1 ml supernatant was frozen in liquid nitrogen and store at −80°C for later using. Beads were washed with 1 ml IP buffer (10 mM Tris pH 8.8, 150 mM NaCl, 0.01% NP-40, 1 mM MgCl2, 1× protease inhibitor, and 5% glycerol) for three times before incubation. After overnight incubation, beads were washed with 1 ml IP buffer for five times. Washed beads were resuspended in 50 μl IP buffer, boiled with 25 μl 5× SDS loading buffer at 95°C, after cooling down on ice, immediately used for Western blot and mass spectrometry analysis in the University of Bern.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.